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Abstract
The post-transcriptional sequence modification of transcripts through RNA editing is an important mechanism for
regulating protein function and is associated with human disease phenotypes. The identification of RNA editing or
RNA-DNA difference (RDD) sites is a fundamental step in the study of RNA editing. However, a substantial number of
false-positive RDD sites have been identified recently. A major challenge in identifying RDD sites is to distinguish
between the true RNA editing sites and the false positives. Furthermore, determining the location of condition-
specific RDD sites and elucidating their functional roles will help toward understanding various biological
phenomena that are mediated by RNA editing. The present study developed RNA-sequence comparison and
annotation for RNA editing (RCARE) for searching, annotating, and visualizing RDD sites using thousands of
previously known editing sites, which can be used for comparative analyses between multiple samples. RCARE also
provides evidence for improving the reliability of identified RDD sites. RCARE is a web-based comparison, annotation,
and visualization tool, which provides rich biological annotations and useful summary plots. The developers of
previous tools that identify or annotate RNA-editing sites seldom mention the reliability of their respective tools. In
order to address the issue, RCARE utilizes a number of scientific publications and databases to find specific
documentations respective to a particular RNA-editing site, which generates evidence levels to convey the reliability of
RCARE. Sequence-based alignment files can be converted into VCF files using a Python script and uploaded to the
RCARE server for further analysis. RCARE is available for free at http://www.snubi.org/software/rcare/.
Introduction
RNA editing is the post-transcriptional alteration of a
single nucleotidesequence in primary messenger RNA
(mRNA) or non-coding RNA (ncRNA) including micro-
RNA (miRNA) transcripts [1]. The most widespread
type of RNA editing in mammals is A-to-I editing,
which is mediated by the adenosine deaminases acting
on RNA (ADAR) enzyme [2-4]. Recent developments in
DNA and RNA sequencing (RNA-Seq) technologies
have led to the rapid identification of several forms of
RNA editing in human cell lines, including G-to-A, C-
to-U, T-to-C, C-to-A, G-to-C, T-to-A, and A-to-T [5,6].
Most of the RNA editing or RNA-DNA difference
(RDD) sites are located within intron, 5’ untranslated
region (UTR), 3’UTR [7], and Alu sequences. However,
when RNA editing events occur in the coding region,
they can cause nonsynonymous protein coding substitu-
tions, alternative splicing, and changes in gene expres-
sion [7-9]. In addition, RNA editing can affect the
activity of ncRNAs such as miRNA, siRNA (short inter-
fering RNA), and piRNA (piwi-interacting RNA) [10].
Many RNA editing events are associated with a variety
of human diseases such as epilepsy, brain ischemia,
depression, and brain tumors [1].
In the last few years, huge amounts of DNA and
RNA-Seq data have been generated and stored in public
repositories such as GEO (www.ncbi.nlm.nih.gov/geo/)
and ENCODE (http://genome.ucsc.edu/ENCODE/). In
response, many tools have been developed for detecting
or annotating RNA editing and RDD sites. Prediction
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tools for novel RNAediting sitessuch as rddChecker
(http://genomics.jhu.edu/software/rddChecker/) perform
RNA-DNA sequence comparisons with RNA-Seq and
genomic DNA sequence data. The rddChecker searches
for RDDs, filters known single-nucleotide polymorph-
isms, and determines novel RNA editing sites by
comparison with known RNA editing sites. However,
the rddChecker is known to suffer from false-positive
results. And many of the RNA editing sites reported by
Li et al. [11] were subsequently demonstrated to be false
positives [12,13]. From this point of view, a major chal-
lenge in identifying RNA editing or RDD sites is distin-
guishing between the true RNA editing sites and the
false positives.
Several RNA editing-site databases have been devel-
oped that include information gathered from the litera-
ture or from manually accrued datasets such as
DARNED (a database of RNAediting in humans) [14]
and RADAR (a rigorously annotated database of A-to-I
RNA editing) [15]. DARNED is a famous database that
provides about 42,000 human RNA editing sites, while
RADAR provides 1,343,464 human, 7,272 mouse, and
3,155 fly-tissue-specific RNA editing sites. Web-based
RNA editing site annotation tools have been developed
to take advantage of these databases. For example,
ExpEdit [16] is an annotation tool that use the
DARNED system for RNA editing sites. ExpEdit
increases reliability by using more reliable data com-
pared toother prediction tools, but is not able to identify
novel RNA editing sites. It provides a user-friendly web
interface for uploading raw RNA-Seq data such as
FASTQ, SAM (sequence alignment map), and BAM
(binary alignment map) files, and for exploring RNA
editing. However, uploading raw RNA-Seq data cannot
be completed within a practical time frame with this
tool (i.e., it takes approximately 28 h to upload 700-MB
BAM files). The Python package REDItools, which were
developed to overcome the long uploading problem
[17], perform novel RNA editing site detection and
known RNA editing site annotation using DNA
sequence and RNA-Seq data together from the same
sample/individual or RNA-Seq data alone. VIRGO [18]
is a web-based tool for identifying putative A-to-I edit-
ing sites in DNA sequences. However, Expedit and
REDItools do not provide validity or reliability levelsfor
each RNA editing site in the results data, and VIRGO
provides only an A-to-I RNA editing form.
This study presented a new tool for RNA-Seq compari-
son and annotation for RNA editing (RCARE), which
determines condition-dependent RNA editing sites, pro-
vides rich systematic annotations and the evidence level
of each RNA editing site. It identifies novel RNA editing
sites in the same/individual DNA sequence and RNA-Seq
variant call format (VCF) data, and delivers ‘executive
summary’ plots for the annotation and comparison of
multiple samples with RNA-Seq data through a user-
friendly web interface. It also provides a Python script
that users can implement to preprocess raw RNA-Seq
data and convert FASTQ and BAM files into RNA VCF
files within a practical time frame on a desktop compu-




RCARE integrates 314,880, 6,830, and 13,018 human
mRNA editing sites downloaded from DARNED
(NCBI37/hg19) [14] and human ENCODE RNA-Seq data
[1], and Bahn et al, respectively. [5]. The reference-based
evidence level of each RNA editing site was generated by
downloading 1,379,404 and 10,115 human RNA editing
sites (hg19) from RADAR [15] and Li et al. [11]. We also
downloaded Homo_sapiens.GR-Ch37.69.gtf and Repeat-
Masker database information from Ensembl (ensembl.
org) and UCSC (http://genome.ucsc.edu/buildGRCCh37/
hg19) to annotate the RDD site into one of the following
categories: ncRNA, Ensembl Gene (ENSG) ID, Transcript
(ENST) ID, Exon ID (ENSE), and repetitive element (Alu,
nonrepetitive). ANNOVAR (http://www.openbioinfor-
matics.org/annovar/) [19] was also used to annotate the
following genomic features: intron, intergenic, splicing
region, downstream, upstream, 3’UTR, 5’UTR, and
synonymous/nonsynonymous information (Table 1).
RNA-Seq data preprocessing
RCARE provides a Python script for the automated con-
version of a FASTQ or BAM file obtained from an
RNA-Seq experiment into a VCF file with the hg19
reference genome (Figure 1A). TopHat [20], SAMtools
[21], VCFtools [22], Tabix [23], and Bowtie2 [24] are
run by the downloaded script on the client side to avoid
the time-consuming uploading of huge RNA-Seq data.
The parameters for TopHat and SAMtools are easily
modifiable. Conversion utility consists of 2 types. The
full version Conversion utility contains indispensable
tools such as tophat, python script for BAM to VCF
conversion, python script for DNA/RNA sequence var-
iant comparison for finding novel RDD or RNA editing
candidate sites and sample files for testing analysis.
However, if a user already installed tools such as tophat,
samtools and tabix, the user could download the light
version Conversion utility. The light version excludes
the aforementioned tools for faster downloads. Details
of the data-processing pipeline are shown in Figure 1. If
the user wants to use other tools for read mapping and
variant calling, he could use other tools such as STAR
and GATK, respectively, to create a VCF file as input
for Annotation or Known-RNA-editing-site-compare
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Table 1. Database resources for RNA editing, listing the sources of data currently included in RCARE, specific entries in
the database, and the total unique RNA editing site covered by each data type
No. of tissue types No. of RNA editing sites No. of Alu sequences No. of references
DARNED 29 314,880 15,783 34
ENCODE 27 6,840 347 18
RADAR 30 291,901 14,318 31
Bahn et al. [5] 27 12,810 2,916 15
Li et al. [11] 1 1 0 1
Total 114 626,432 33,364 99
Figure 1 RCARE RNA-Seq data processing steps and annotation result visualization. A) Conversion utility RNA-Seq data processing
pipeline. B) Web interface for annotation and comparison analyses. C) Summary plots of annotation results
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functions. When both the DNA sequencing and RNA-
Seq data are available, the RCARE RDD-compare func-
tion can be used to compare the paired VCF files
created from those data. It is based on a python script
and performs a comparison between RNA and DNA
sequence variants according to chromosome, position,
and reference/alternative sequences. This compare func-
tion can detect novel RDD or RNA editing candidate
sites from DNA and RNA-VCF files. More precise
detection of RNA editing sites requires both DNA and
RNA VCF files obtained from the same/individual
sample.
Comparison RNA editing sites
In RCARE, Known-RNA-editing-site-compare functions
are functions which identifies RNA sites that are differen-
tially edited between samples according to chromosome,
position, and reference/alternative sequence. It also
identifies RNA editing sites intersecting between input
RNA-Seq samples. A detailed method for compare func-
tions was described in Fig S3.
Construction of the web interface
RCARE is a web-based application that was created
using HTML5 (Hypertext Markup Language 5), CSS3
(Cascading Style Sheets 3), jQuery, and Highcharts API
(http://www.highcharts.com/). It also provides four func-
tionalities: RNA-Seq data preprocessing, comparison,
annotation, and visualization.
Result
We collected 321,008 RNA editing sites from DARNED
(NCBI37/hg19) [14] and human ENCODE RNA-Seq
data [1], and Bahn et al. [5]. The data sets comprised
154 samples in 30 sample types, 23 papers, and 11,299
genes with 12 different types of RNA editing sites
(Figure 2). RCARE annotates each RNA editing site with
nine annotation categories. The RCARE annotation
function checks whether an editing site: (1) creates
synonymous vs. nonsynonymous changes, (2) is located
at a splicing junction, (3) has certain genomic features,
(4) is Alu-associated, and (5) is located in a ncRNA; it
also annotates (6) gene information (i.e., gene symbol,
various IDs; see additional files), (7) sample origin, (8)
reference articles, and (9) the reference-based evidence
level. In addition, it provides the unique RNA editing
sites of each sample and the intersection/difference
between all pairwise sample comparisons with 17 useful
biological annotations (Table 2).
Although the detection of RNA editing sites is impor-
tant, the reliability of the RNA editing site is even more
so. To enhance the reliability of the detected RNA edit-
ing sites, we generated Evidence levels according to the
number of resources reporting corresponding RNA
editing. First, we collected five RNA editing site-related
resources (DARNED, RADAR, Bahn et al. [5], Li et al.
[11], Park et al. [12]) and Alu sequence information
(RepeatMasker, www.repeatmasker.org/). Second, we
integrated aforementioned resources according to chro-
mosome, position, and reference/alternative sequences
and generated evidence levels according to the number
of resources, which addressed corresponding RNA edit-
ing sites. Evidence levels consist of five levels (A-E),
where A is the highest level (Table 3, Additional file 1).
For example, if one RNA editing site is assigned level A,
it appears in all five of the databases/papers searched.
Whereas, the lowest class (E) represents the lowest level
of evidence for RNA editing sites, whereby they appear
in only one of the reference resources; 85% of RNA
editing sites in integrated data belong to class D,
appearing in two of the resources. This allows the user
to decide whether a detected site is a false positive or
a true positive, according to the graded scale of the
evidence level.
The web interface consists of three sections: user
manual, download, and analysis. The user manual sec-
tion provides instructions regarding the conversion utili-
ties, annotation, comparison, and results description
(Figure 1B). All manual files can be downloaded as
PDF files. The download section provides conversion
utilities that can be downloaded. We provide two ver-
sions of the conversion utilities: full and light. The full
version includes all RNA-Seq processing tools such as
TopHat, while the light version does not. The analysis
section provides annotation and comparison analysis.
The annotation part provides 16 useful biological anno-
tations and the evidence level of each RNA editing site
from the VCF format of the RNA-Seq data. The com-
pare part provides the RNA editing sites of each sample
and the intersection/difference between all pairwise
samples with 16 useful biological annotations and
evidence levels. The results page provides summary plots
based on annotation categories including the distribu-
tions of genomic features, genes, ncRNAs, synonymous
vs. nonsynonymous changes, types of RNA editing, and
the distributions of detected RNA editing sites in each
chromosome or sample (Figure 1C). All image files for
plots and annotation files can be downloaded. The test
results with three RNA-Seq data sets for MCF-7
(a breast cancer cell line), HUVEC (a human umbilical
vein endothelial cell line) and HeLa-S3 (a cervical car-
cinoma cell line) downloaded from ENCODE (http://
genome.ucsc.edu/ENCODE/) yielded 2437, 646 and
1190 RNA editing sites, respectively; we obtained 205,
605 and 334 RNA editing sites that had evidence levels
of A-C from HUVEC, MCF-7 and HeLa-S3; however,
these represent only 31.7%, 24.8% and 28.07% of the
total RNA editing sites. This finding shows that a good
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Figure 2 Data compositions. A) Venn diagram representing the number of RNA editing sites shared between DARNED, ENCODE, and Bahn et
al. [5]. B) Number of RNA editing sites for each sample type. C) Bar plot representing the number of RNA editing sites for each editing type. D)
Bar plot representing the number of RNA editing sites for each chromosome. E) Number of RNA editing sites for each genomic feature.
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evidence level is essential for RNA editing detection
and annotation analysis. We also accomplish the
Known-RNA-editing-site-compare functions between
MCF-7 and HUVEC. As a result, we identified 2,080
breast-cancer-specific RNA editing site were detected
from MCF-7. These results demonstrate the impor-
tance of detecting condition-specific RNA editing sites.
We measured execution times of Expedit and RCARE
using a 37.3 Mb sample bam file. Conversion processing
of RCARE was performed in 192 seconds on a 3.0 GHz
CPU, 2048 MB RAM desktop environment for converting
BAM to VCF. RCARE RNA editing site annotations took
7 seconds under 14.19 MBps network environments.
Discussion
Efficient and user-friendly web-based system for trust-
worthy RNA-editing-site annotation, comparison and
graph visualization. RCARE contains 321,008 human
RNA editing sites with rich biological annotations and
useful summary plots, as well as evidence levels to indi-
cate the reliability of each RNA editing site. Further-
more, it provides a tool for converting sequence-based
alignment files into VCF files using a Python script; con-
verted VCF files can be uploaded to the RCARE server
for further analysis. The RCARE web interface can be
used to easily annotate and visualize VCF-formatted
RNA-Seq data, and to download results into CSV and
JPG files.
Identification of novel RNA-editing sites became the
focus of RNA-editing research about 2~3 years ago
[1,5,11]. In recent years, however, the spotlight has
shifted to analyzing reliability of identified RNA-editing
sites because research revealed that numerous RNA-
editing sites were, in fact, false positives. We anticipate






1 Chr Chromosome of the RNA editing site in the reference genome. [5,11,14]
2 Pos Coordinate of the RNA editing site in the reference genome.
3 In DNA Base of the RNA editing site in the DNA reference sequence.
4 In RNA Base of the RNA editing site in the RNA sequence of sample.
5 Gene Gene name to which the RNA editing site belongs.
6 Evidence level The evidence level consists of five levels (A-E), where A is highest level (e.g., if an RNA
editing site had level “A,” it appeared in all five of the resource databases/papers used).
*Level A: The RNA editing site appeared in five resources (evidence No. 5).
*Level B: The RNA editing site appeared in four resources (evidence No. 4).
*Level C: The RNA editing site appeared in three resources (evidence No. 3).
*Level D: The RNA editing site appeared in two resources (evidence No. 2).
*Level E: The RNA editing site appeared in one resource (evidence No. 1).
[5,11,14,15]
RepeatMasker
7 Strand + for positive strand; - for negative strand. [5,11,14]
8 Source This field contains information regarding the tissue source from which the RNA editing
instance was obtained.
9 PubMed ID This field provides the reference article from which the RNA editing data was extracted.
10 Alu This field provides information of Alu at the RNA editing site. RepeatMasker
11 Data reference Reference database. Each database or
reference
12 ENSG Ensembl Gene ID. GTF(Homo sapiens,
13 ENST Ensembl Transcript ID.
14 ENSE Ensembl Exon ID. GRCH37.17) in Ensembl
15 Genomic feature Genomic feature of the RNA editing site.
*Exonic: the variant overlaps a coding exon.
*Splicing: the variant is within 2 bp of a splicing junction.
*ncRNA: the variant overlaps a transcript without coding annotation in the gene
definition.
*5’UTR: the variant overlaps a 5’ untranslated region.
*3’UTR: the variant overlaps a 3’ untranslated region.
*Intronic: the variant overlaps an intron.
*Upstream: the variant overlaps the 1-kb region upstream of the transcription start site.
*Downstream: the variant overlaps the 1-kb region downstream of the transcription end
site.




Synonymous or nonsynonymous substitutions at the RNA editing site. [19]
17 Noncoding RNA This field indicates whether the location of an RNA editing site is in ncRNA. GTF (Homo sapiens,
GRCH37.17) in Ensembl
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that RCARE’s evidence level will greatly augment the field
of RNA-editing site research. RCARE will help toward the
identification of trustworthy RNA editing sites.
Additional material
Additional file 1: Number of RNA editing sites for each genomic feature
within each evidence level. A) Number of RNA editing sites at each
evidence level. B) Evidence level annotations in relation to genomic
features. The enrichments for genic features at each evidence level from
RCARE are also shown.
Additional file 2: The ratio of each evidence level within three cell line
RNA-seq data. A) The ratio of evidence levels A-C versus D-E in detected
RNA-editing sites within three cell lines including MCF-7 (a breast cancer
cell line), HUVEC (a human umbilical vein endothelial cell line) and HeLa-
S3 (a cervical carcinoma cell line). B) Number of RNA editing sites at each
evidence level within three cell llines.
Additional file 3: RCARE webpage user manuals.
Additional file 4: RCARE convert utilities manuals.
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